Vimarsana
Biggest News Aggregation in the World

Page 3 - Study Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Manager Today - Breaking & Trending Today

Coffee with Samso: All about the REE market with OD6 Metals - Vimarsana News

Coffee with Samso: All about the REE market with OD6 Metals

Coffee with Samso Episode 170 is with Brett Hazelden, managing director and CEO of OD6 Metals Ltd (ASX:OD6). The space in the rare earth sector is maturing...

OceanaGold Provides Exploration Update for Wharekirauponga, Haile and Didipio - Vimarsana News

OceanaGold Provides Exploration Update for Wharekirauponga, Haile and Didipio

OceanaGold Corporation (TSX: OGC) (“OceanaGold” or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/oceanagold-corp/) is

Coffee with Samso: OD6 Metals Ltd - the rare earth elements story - Vimarsana News

Coffee with Samso: OD6 Metals Ltd - the rare earth elements story

Coffee with Samso Episode 158 is with Brett Hazelden, Managing Director and CEO of OD6 Metals Ltd (ASX:OD6). The recent rise in rare earth companies has...

Fireweed Announces New Director and Grant of Stock Options - Vimarsana News

Fireweed Announces New Director and Grant of Stock Options

VANCOUVER, British Columbia, Sept. 06, 2022 -- FIREWEED METALS CORP. is pleased to announce the appointment of Peter Hairsine to the Board of Directors and the grant of stock options. New... | September 6, 2022

Average UK Clinical Research Salaries in 2022 - Vimarsana News

Average UK Clinical Research Salaries in 2022

With the UK’s Clinical Research industry booming, and with the current job market becoming increasingly candidate-driven, 2022 is an excellent time to be considering a career move within or into Clinical Research. Following on from our previous article outlining 10 Clinical Research career paths, we’ve used ...